Objective:

Present expert perspectives on the main barriers to making cell and gene therapies widely accessible and where the industry should focus its efforts.

Approach:

• Format: A roundtable produced by IBTV in collaboration with The Medicine Maker and moderated by Dalip Sethi of Terumo Blood and Cell Technologies.
• Participants: The discussion features Louis Cicchini of Cencora, Michael Baker of Fujifilm Biotechnologies, and Heather Purvis of Title21 Health Solutions.
• Topics: Participants consider industry priorities, opportunities for collaboration, and whether AI and other emerging technologies could help address barriers to patient access.

Key Findings:

• The article identifies complex manufacturing, fragmented data systems, regulatory requirements, limited care sites, and uncertain reimbursement as potential barriers.
• The context does not report a specific bottleneck selected by the participants or detailed roundtable conclusions.

Interpretation:

The article introduces a discussion of challenges to broader access; the provided context does not specify which challenge the experts consider the greatest.

Limitations:

• The supplied context is an introduction to the roundtable and does not include its discussion or conclusions.

Sources:

• Article context provided by the user